IBDEI1TG ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,29013,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29013,1,2,0)
;;=2^97533
;;^UTILITY(U,$J,358.3,29013,1,3,0)
;;=3^Sensory Integrative Techniques,per 15 min
;;^UTILITY(U,$J,358.3,29014,0)
;;=97537^^117^1451^1^^^^1
;;^UTILITY(U,$J,358.3,29014,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29014,1,2,0)
;;=2^97537
;;^UTILITY(U,$J,358.3,29014,1,3,0)
;;=3^Community/Work Reintegration,Ea 15 min
;;^UTILITY(U,$J,358.3,29015,0)
;;=97545^^117^1451^6^^^^1
;;^UTILITY(U,$J,358.3,29015,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29015,1,2,0)
;;=2^97545
;;^UTILITY(U,$J,358.3,29015,1,3,0)
;;=3^Work Hardening/Conditioning,Init 2 hrs
;;^UTILITY(U,$J,358.3,29016,0)
;;=97546^^117^1451^7^^^^1
;;^UTILITY(U,$J,358.3,29016,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29016,1,2,0)
;;=2^97546
;;^UTILITY(U,$J,358.3,29016,1,3,0)
;;=3^Work Hardening/Conditioning,Ea Addl Hr
;;^UTILITY(U,$J,358.3,29017,0)
;;=98961^^117^1451^3^^^^1
;;^UTILITY(U,$J,358.3,29017,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29017,1,2,0)
;;=2^98961
;;^UTILITY(U,$J,358.3,29017,1,3,0)
;;=3^Self-Mgmt Educ/Trng,2-4 Pts,Ea 30 min
;;^UTILITY(U,$J,358.3,29018,0)
;;=98962^^117^1451^4^^^^1
;;^UTILITY(U,$J,358.3,29018,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29018,1,2,0)
;;=2^98962
;;^UTILITY(U,$J,358.3,29018,1,3,0)
;;=3^Self-Mgmt Educ/Trng,5-8 Pts,Ea 30 min
;;^UTILITY(U,$J,358.3,29019,0)
;;=99078^^117^1451^2^^^^1
;;^UTILITY(U,$J,358.3,29019,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29019,1,2,0)
;;=2^99078
;;^UTILITY(U,$J,358.3,29019,1,3,0)
;;=3^Group Health Education/Counseling
;;^UTILITY(U,$J,358.3,29020,0)
;;=96372^^117^1452^1^^^^1
;;^UTILITY(U,$J,358.3,29020,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29020,1,2,0)
;;=2^96372
;;^UTILITY(U,$J,358.3,29020,1,3,0)
;;=3^Ther/Proph/Diag Inj SC/IM
;;^UTILITY(U,$J,358.3,29021,0)
;;=96402^^117^1452^2^^^^1
;;^UTILITY(U,$J,358.3,29021,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29021,1,2,0)
;;=2^96402
;;^UTILITY(U,$J,358.3,29021,1,3,0)
;;=3^Anti-Neoplastic,Hormonal,IM
;;^UTILITY(U,$J,358.3,29022,0)
;;=J1630^^117^1452^3^^^^1
;;^UTILITY(U,$J,358.3,29022,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29022,1,2,0)
;;=2^J1630
;;^UTILITY(U,$J,358.3,29022,1,3,0)
;;=3^Haloperidol,up to 5mg
;;^UTILITY(U,$J,358.3,29023,0)
;;=J1631^^117^1452^4^^^^1
;;^UTILITY(U,$J,358.3,29023,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29023,1,2,0)
;;=2^J1631
;;^UTILITY(U,$J,358.3,29023,1,3,0)
;;=3^Haloperidol Decanoate,per 50mg
;;^UTILITY(U,$J,358.3,29024,0)
;;=J2680^^117^1452^5^^^^1
;;^UTILITY(U,$J,358.3,29024,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29024,1,2,0)
;;=2^J2680
;;^UTILITY(U,$J,358.3,29024,1,3,0)
;;=3^Fluphenazine Decanoate,up to 25mg
;;^UTILITY(U,$J,358.3,29025,0)
;;=J2794^^117^1452^6^^^^1
;;^UTILITY(U,$J,358.3,29025,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29025,1,2,0)
;;=2^J2794
;;^UTILITY(U,$J,358.3,29025,1,3,0)
;;=3^Risperidone,Long Acting,per 0.5mg
;;^UTILITY(U,$J,358.3,29026,0)
;;=90867^^117^1453^3^^^^1
;;^UTILITY(U,$J,358.3,29026,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29026,1,2,0)
;;=2^90867
;;^UTILITY(U,$J,358.3,29026,1,3,0)
;;=3^TMS,Initial
;;^UTILITY(U,$J,358.3,29027,0)
;;=90868^^117^1453^4^^^^1
;;^UTILITY(U,$J,358.3,29027,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,29027,1,2,0)
;;=2^90868
;;^UTILITY(U,$J,358.3,29027,1,3,0)
;;=3^TMS,Subseq Delivery & Mgmt,per session
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1TG 3825 printed Sep 23, 2025@19:51:29 Page 2
IBDEI1TG ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,29013,1,0)
+2 ;;=^358.31IA^3^2
+3 ;;^UTILITY(U,$J,358.3,29013,1,2,0)
+4 ;;=2^97533
+5 ;;^UTILITY(U,$J,358.3,29013,1,3,0)
+6 ;;=3^Sensory Integrative Techniques,per 15 min
+7 ;;^UTILITY(U,$J,358.3,29014,0)
+8 ;;=97537^^117^1451^1^^^^1
+9 ;;^UTILITY(U,$J,358.3,29014,1,0)
+10 ;;=^358.31IA^3^2
+11 ;;^UTILITY(U,$J,358.3,29014,1,2,0)
+12 ;;=2^97537
+13 ;;^UTILITY(U,$J,358.3,29014,1,3,0)
+14 ;;=3^Community/Work Reintegration,Ea 15 min
+15 ;;^UTILITY(U,$J,358.3,29015,0)
+16 ;;=97545^^117^1451^6^^^^1
+17 ;;^UTILITY(U,$J,358.3,29015,1,0)
+18 ;;=^358.31IA^3^2
+19 ;;^UTILITY(U,$J,358.3,29015,1,2,0)
+20 ;;=2^97545
+21 ;;^UTILITY(U,$J,358.3,29015,1,3,0)
+22 ;;=3^Work Hardening/Conditioning,Init 2 hrs
+23 ;;^UTILITY(U,$J,358.3,29016,0)
+24 ;;=97546^^117^1451^7^^^^1
+25 ;;^UTILITY(U,$J,358.3,29016,1,0)
+26 ;;=^358.31IA^3^2
+27 ;;^UTILITY(U,$J,358.3,29016,1,2,0)
+28 ;;=2^97546
+29 ;;^UTILITY(U,$J,358.3,29016,1,3,0)
+30 ;;=3^Work Hardening/Conditioning,Ea Addl Hr
+31 ;;^UTILITY(U,$J,358.3,29017,0)
+32 ;;=98961^^117^1451^3^^^^1
+33 ;;^UTILITY(U,$J,358.3,29017,1,0)
+34 ;;=^358.31IA^3^2
+35 ;;^UTILITY(U,$J,358.3,29017,1,2,0)
+36 ;;=2^98961
+37 ;;^UTILITY(U,$J,358.3,29017,1,3,0)
+38 ;;=3^Self-Mgmt Educ/Trng,2-4 Pts,Ea 30 min
+39 ;;^UTILITY(U,$J,358.3,29018,0)
+40 ;;=98962^^117^1451^4^^^^1
+41 ;;^UTILITY(U,$J,358.3,29018,1,0)
+42 ;;=^358.31IA^3^2
+43 ;;^UTILITY(U,$J,358.3,29018,1,2,0)
+44 ;;=2^98962
+45 ;;^UTILITY(U,$J,358.3,29018,1,3,0)
+46 ;;=3^Self-Mgmt Educ/Trng,5-8 Pts,Ea 30 min
+47 ;;^UTILITY(U,$J,358.3,29019,0)
+48 ;;=99078^^117^1451^2^^^^1
+49 ;;^UTILITY(U,$J,358.3,29019,1,0)
+50 ;;=^358.31IA^3^2
+51 ;;^UTILITY(U,$J,358.3,29019,1,2,0)
+52 ;;=2^99078
+53 ;;^UTILITY(U,$J,358.3,29019,1,3,0)
+54 ;;=3^Group Health Education/Counseling
+55 ;;^UTILITY(U,$J,358.3,29020,0)
+56 ;;=96372^^117^1452^1^^^^1
+57 ;;^UTILITY(U,$J,358.3,29020,1,0)
+58 ;;=^358.31IA^3^2
+59 ;;^UTILITY(U,$J,358.3,29020,1,2,0)
+60 ;;=2^96372
+61 ;;^UTILITY(U,$J,358.3,29020,1,3,0)
+62 ;;=3^Ther/Proph/Diag Inj SC/IM
+63 ;;^UTILITY(U,$J,358.3,29021,0)
+64 ;;=96402^^117^1452^2^^^^1
+65 ;;^UTILITY(U,$J,358.3,29021,1,0)
+66 ;;=^358.31IA^3^2
+67 ;;^UTILITY(U,$J,358.3,29021,1,2,0)
+68 ;;=2^96402
+69 ;;^UTILITY(U,$J,358.3,29021,1,3,0)
+70 ;;=3^Anti-Neoplastic,Hormonal,IM
+71 ;;^UTILITY(U,$J,358.3,29022,0)
+72 ;;=J1630^^117^1452^3^^^^1
+73 ;;^UTILITY(U,$J,358.3,29022,1,0)
+74 ;;=^358.31IA^3^2
+75 ;;^UTILITY(U,$J,358.3,29022,1,2,0)
+76 ;;=2^J1630
+77 ;;^UTILITY(U,$J,358.3,29022,1,3,0)
+78 ;;=3^Haloperidol,up to 5mg
+79 ;;^UTILITY(U,$J,358.3,29023,0)
+80 ;;=J1631^^117^1452^4^^^^1
+81 ;;^UTILITY(U,$J,358.3,29023,1,0)
+82 ;;=^358.31IA^3^2
+83 ;;^UTILITY(U,$J,358.3,29023,1,2,0)
+84 ;;=2^J1631
+85 ;;^UTILITY(U,$J,358.3,29023,1,3,0)
+86 ;;=3^Haloperidol Decanoate,per 50mg
+87 ;;^UTILITY(U,$J,358.3,29024,0)
+88 ;;=J2680^^117^1452^5^^^^1
+89 ;;^UTILITY(U,$J,358.3,29024,1,0)
+90 ;;=^358.31IA^3^2
+91 ;;^UTILITY(U,$J,358.3,29024,1,2,0)
+92 ;;=2^J2680
+93 ;;^UTILITY(U,$J,358.3,29024,1,3,0)
+94 ;;=3^Fluphenazine Decanoate,up to 25mg
+95 ;;^UTILITY(U,$J,358.3,29025,0)
+96 ;;=J2794^^117^1452^6^^^^1
+97 ;;^UTILITY(U,$J,358.3,29025,1,0)
+98 ;;=^358.31IA^3^2
+99 ;;^UTILITY(U,$J,358.3,29025,1,2,0)
+100 ;;=2^J2794
+101 ;;^UTILITY(U,$J,358.3,29025,1,3,0)
+102 ;;=3^Risperidone,Long Acting,per 0.5mg
+103 ;;^UTILITY(U,$J,358.3,29026,0)
+104 ;;=90867^^117^1453^3^^^^1
+105 ;;^UTILITY(U,$J,358.3,29026,1,0)
+106 ;;=^358.31IA^3^2
+107 ;;^UTILITY(U,$J,358.3,29026,1,2,0)
+108 ;;=2^90867
+109 ;;^UTILITY(U,$J,358.3,29026,1,3,0)
+110 ;;=3^TMS,Initial
+111 ;;^UTILITY(U,$J,358.3,29027,0)
+112 ;;=90868^^117^1453^4^^^^1
+113 ;;^UTILITY(U,$J,358.3,29027,1,0)
+114 ;;=^358.31IA^3^2
+115 ;;^UTILITY(U,$J,358.3,29027,1,2,0)
+116 ;;=2^90868
+117 ;;^UTILITY(U,$J,358.3,29027,1,3,0)
+118 ;;=3^TMS,Subseq Delivery & Mgmt,per session
